Skip to main content
. 2018 Sep 17;103(11):4176–4186. doi: 10.1210/jc.2018-01446

Figure 3.

Figure 3.

(A) Baseline and (B) final visit plasma glucose (diamonds) and insulin (triangles, dotted line) concentrations, and (C) baseline and (D) final visit glucose infusion rates during low-dose (min 0 to 120) and high-dose (min 120 to 240) hyperinsulinemic euglycemic clamp. Data are represented as means and SEM (bars). GIR, glucose infusion rate.